Oxygen free radicals generated during reoxygenation after cardiac arrest may impair recovery of cerebral blood flow and function. In a randomized study in vivo, we tested the following anti-free radical combination therapy administered at the beginning of cardiopulmonary resuscitation after apnea-induced cardiac arrest of 7 minutes: 1) ventilation with 100% nitrogen for 30 seconds to allow the delivery of therapy before oxygen, 2) 10 mg/kg i.a. superoxide dismutase followed by 10 mg/kg i.v. over 1 hour to scavenge the superoxide anion radical, and 3) 20 mg/kg i.v. deferoxamine over 1 hour to prevent membrane lipid peroxidation. We evaluated the effects of this combined treatment on the recovery of cardiovascular variables, cerebral blood flow and oxygen consumption, and somatosensory evoked potentials in 20 dogs 6 hours after resuscitation. Compared with standard treatment (n = 10), the combined treatment (n = 10) did not affect cardiovascular variables, significantly mitigated cerebral blood flow changes after cardiac arrest, and enhanced recovery of somatosensory evoked potentials. We conclude that oxygen free radicals play a role in the pathogenesis of the arrestrelated derangements of cerebral blood flow and function that are effectively reduced by this combined treatment; we recommend evaluation of its components in outcome studies. (Stroke 1987;18:869-878)
C erebral damage after cardiac arrest is believed to be the combined result of events occurring during the initial period of temporary complete global ischemia and the subsequent period of recirculation and reoxygenation (for reviews see Refs. 1 and 2). Although definitive proof of its occurrence in the brain in vivo is still controversial, 34 the production of oxygen free radicals after ischemia is widely recognized to play a role in reperfusion injury in vitro and in extracerebral organs. 5 " 9 During ischemia, several events predispose to the formation of oxygen radicals. The brain concentration of hypoxanthine increases 10 " due to extensive breakdown of ATP; the enzyme xanthine dehydrogenase, known to be present at least in brain endothelial cells, 12 is converted into xanthine oxidase by a calcium-activated protease 13 ; and the cerebral content of arachidonic acid rises 1413 as the result of activation of phospholipase A 2 . 16 During reoxygenation, a burst of superoxide radical production occurs as a byproduct of the oxidation of hypoxanthine 13 and arachidonate metabolism via cyclooxygenase and lipoxygenase." Superoxide radicals promote the release of iron from ferritin, 18 probably
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causing the increase in brain concentrations of free iron that occurs during reperfusion after cardiac arrest." Free iron catalyzes the conversion of superoxide radicals into highly reactive hydroxyl radicals; free iron is also necessary for the initiation and propagation of membrane lipid peroxidation, 20 which do not occur if iron is absent or chelated. 21 Lipid peroxidation in the brain has recently been shown to occur in vivo following reperfusion after incomplete ischemia. 22 Oxygen free radicals elicit cytotoxic and vasogenic edema, alter endothelial and blood-brain barrier permeability, 23 increase microvascular permeability, 24 induce endothelial functional and morphologic abnormalities, 23 enhance the production of vasoactive arachidonate metabolites 26 through the generation of lipid hydroperoxides, 20 inhibit mitochondrial respiration, 27 and change phospholipid composition, thereby altering membrane structure and function. 28 Therefore, directly or by initiating lipid peroxidation, oxygen free radicals may interfere with the postischemic recovery of cerebral blood flow, metabolism, and function.
The data described above suggest three approaches to counteract the production of oxygen free radicals and their effects during recirculation after ischemia: first, anoxic reperfusion to deliver scavengers with reperfusion before reoxygenation 7 ; second, oxygen free radical scavengers such as superoxide dismutase (SOD) to block the effects of superoxide anion radicals, 29 preventing their reaction with hydrogen peroxide to generate highly reactive hydroxyl radicals 20 and preventing the release of iron from ferritin. 21 In vivo, SOD protects tissues in a variety of extracerebral models of ischemia (for reviews see Refs. 5, 9, and 13). In the brain, SOD prevents the vasodilatation and endothelial damage induced by acute hypertension. 23 Third, deferoxamine, a chelator of ferric iron, prevents the generation of hydroxyl radicals and the initiation and propagation of membrane lipid peroxidation. 21 In vivo, deferoxamine improved survival of neurologically intact animals after 6 minutes of cardiac arrest 30 and reduced the degree of free-radical-mediated vascular injury in the lungs. 31 We explored the effect of a combined treatment consisting of 100% N 2 for 30 seconds, SOD, and deferoxamine administered at the beginning of cardiopulmonary resuscitation (CPR) on cerebral blood flow (CBF), oxygen metabolism (CMR0 2 ), and somatosensory evoked potentials (SEPs) in a dog model of 7-minute asphyxial cardiac arrest.
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Materials and Methods
Twenty-three unpremedicated healthy male mongrel dogs averaging 22.3 kg body wt (range 17.0-28.6 kg) were fasted overnight with free access to water. Anesthesia was induced with 15 mg/kg i.m. ketamine. After insertion of peripheral intravenous catheters, 10 /u,g/kg fentanyl and 2 mg/kg succinylcholine were administered. The dogs were intubated with cuffed endotracheal tubes and received mechanical intermittent positive pressure controlled ventilation (IPPV) with a mixture of 66% N 2 O and 33% O 2 using a Harvard Model 613 dual-phase respirator pump (South Natick, Mass.). Tidal volume was 15 ml/kg, and ventilatory frequency was adjusted to achieve a Paco2 of 30-35 mm Hg. Continuous i.v. infusions of 10-15 ^ig/kg/hr fentanyl, 0.1 mg/kg/hr pancuronium, and 4 ml/kg/hr 5% dextrose in 0.45% NaCl were started. Catheters were inserted in the ascending aorta for monitoring mean arterial pressure (MAP) using a Statham Model P23 ID pressure transducer (Gould Inc., Hato Rey, Puerto Rico) and for intraaortic injection of drugs. Pulmonary artery 7-French balloon catheters were inserted via the femoral vein for monitoring central venous pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac output by thermodilution using an Edwards Laboratories Model 9520 (American Hospital Supply Co., Santa Ana, Calif.), and temperature. Foley catheters were inserted, and urine output was monitored. Peripheral leads were used for electrocardiographic monitoring.
Global Cerebral Blood Flow
Global cerebral blood flow (gCBF) was determined by the inert gas saturation-desaturation method using H 2 as the tracer gas. 33 Diamond Electro-Tech Inc. Model 760 platinum H 2 -sensitive electrodes (Ann Arbor, Mich.) embedded in 20-gauge stainless steel needles were positioned in an arteriovenous shunt and in the sagittal sinus 34 for monitoring the arterial and cerebral venous washout of H 2 . The heparin-soaked Teflon arteriovenous shunt, 5 cm in length, was inserted through the left femoral vessels. Two burr holes were drilled in the skull at the midline; one was 2 cm anterior to the occipital protuberance where the H 2 -sensitive electrode was inserted into the sagittal sinus with the tip rostral to the confluence of the sinuses, and the other burr hole was 1 cm posterior to the intersection of the frontal crests where a 20-gauge catheter was inserted into the sagittal sinus and the tip was advanced to near the tip of the H 2 electrode for pressure monitoring and blood sampling. Before each experiment, the H 2 -sensitive electrodes were polarized at 250 mV and assessed to give comparable responses to 0, 5, and 10% H 2 in N 2 . The H 2 concentration was measured with Diamond Electro-Tech Inc. Model 1201 microsensors. For each measurement, the dog was ventilated with 10% H 2 for 10 minutes and then the administration of H 2 was discontinued to obtain washout curves for 15 minutes. Wash-in and washout curves were acquired on-line at 1 data point/sec. Mean gCBF was calculated from the washout curve by the height/area method, taking into account the arterial recirculation (for review of method see Ref. 35 ).
Neurophysiologic Monitoring
Stimulation of the median nerve was achieved with square-wave electrical stimuli applied at 1.3 Hz through percutaneous needle electrodes. Visible twitching of the forepaw before paralysis determined the stimulus intensity used, which ranged between 5 and 15 V. Extradural screws were inserted into the skull; one frontal screw was placed at the intersection of the frontal crests on the midline, and one parietal screw was placed 2 cm from the midline, halfway between the occipital protuberance and the frontal crest, contralateral to the stimulated nerve. Cortical SEPs were recorded from a parietofrontal lead.
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- 37 The electrode pair was connected to one channel of a Grass recorder. A Grass Model 7P511J amplifier (Quincy, Mass.) was used, and upper-and lower-band-pass filters were 1 and 1,000 Hz, respectively. Sixty-four epochs were averaged to obtain each response; the data were stored on magnetic tape for further analysis. Absolute latencies and peak-to-peak amplitudes were measured for each response. Amplitudes were expressed as normalized changes from prearrest values. In case of bifid or multiple-peak fragmentation of a wave, latency was measured by interpolation of the wave shape according to the major ascending and descending limbs, and the amplitude was measured tangent to the wave at the interpolated latency.
All parameters were measured simultaneously during H 2 washout 30 minutes before arrest and, after resuscitation, between 15 and 30 minutes, at 1 hour, and every hour thereafter. Simultaneous with measurement of all other variables, a series of at least 10 SEPs was acquired. The averages of these series were used for calculations; the coefficient of variation was used as a measure of variability.
The Before asphyxiation, infusions of fentanyl and pancuronium were discontinued and, simultaneously, the dogs were fully paralyzed with additional 0.5 mg/kg i.v. pancuronium, ventilated for 1 minute with 100% O 2 , and then ventilated for 5 minutes with room air. Asphyxia was induced by disconnecting the ventilator, opening the tracheal tube to room air. Cardiac arrest was considered to start when MAP dropped to ^2 5 mm Hg and continued for 7 minutes. Asphyxiation time, from apnea to cardiac arrest, was recorded and considered to be part of the total insult with cardiac arrest time (7 minutes) and CPR time (defined below).
Before resuscitation, the dogs were randomly assigned to the standard treatment (ST) group or the freeradical treatment (FRT) group (which received standard treatment plus the combined treatment).
Standard Treatment
The ST dogs were resuscitated by simultaneous bolus injection of 0.1 mg/kg epinephrine plus 0.5 meq/kg NaHCO 3 in 4 ml/kg Ringer's solution into the ascending aorta, IPPV with tidal volumes 50 ml higher than prearrest and frequency 45/min, 60 manual sternal compressions/min aiming for an increase in CPR-generated diastolic pressure to 50 mm Hg, and volume loading with 20 ml/kg Ringer's solution for 1 hour. In case of ventricular fibrillation, an external electric countershock of 100 J was applied and repeated every 20-60 seconds as needed, with increments of 50 J to a maximum of 300 J. If resuscitation, i.e., spontaneous MAP of > 5 0 mm Hg, was not accomplished after 3 minutes of CPR, 0.05 mg/kg epinephrine plus 0.5 meq/kg NaHCO 3 in 4 ml/kg Ringer's solution was administered through the central venous catheter. Duration of CPR to restoration of spontaneous circulation (CPR time) was recorded.
After restoration of spontaneous circulation, IPPV was continued, with 100% O 2 and ventilatory parameters as during CPR, for 2 hours. Thereafter, a mixture of 50% N 2 O and 50% O 2 was used, and ventilatory parameters were adjusted to maintain Paco2 at 30-35 mm Hg. MAP was controlled at 85-125 mm Hg with norepinephrine by titrated infusion, central venous pressure was controlled at 6-12 mm Hg with the infusion of 5% dextrose in 0.45% NaCl, base excess was controlled at ± 5 meq/1, and temperature was controlled at 36.5-38.5° C with heated circulating water blankets.
Free-Radical Treatment
The FRT dogs were resuscitated using the standard treatment plus the combined FRT treatment. Aimed at reducing the generation of oxygen free radicals, this consisted of 100% N 2 (instead of O 2 ) for IPPV during the first 30 seconds of CPR, followed by 100% O 2 ; 20 mg/kg bovine SOD (Pharmacia, Uppsala, Sweden), half in 20 ml 0.9% NaCl as an intraaortic bolus at the beginning of CPR and half in 50 ml 0.9% NaCl by continuous i.v. infusion over 1 hour starting at the beginning of CPR; and 20 mg/kg deferoxamine (Ciba, Edison, N.J.) in 500 ml 0.9% NaCl by i.v. infusion over 1 hour starting at the beginning of CPR. The use of N 2 during CPR prevented blinding of the investigators to the treatment given.
Data Analysis
Criteria for eliminating dogs from data analysis were failure to accomplish resuscitation within 5 minutes of CPR, CPR-induced internal hemorrhage assessed at autopsy, or neurosurgical complications such as sagittal sinus thrombosis or intracranial bleeding assessed at autopsy.
At the end of the experiments, all variables were analyzed blindly as to the treatment received by the dogs. Tests of skewness and kurtosis were used to assess normality of the distribution of all variables before arrest. Changes from prearrest values within a group were evaluated by analysis of variance followed by a Bonferroni t test to isolate the difference. Groups were compared using Student's f test for unpaired data. A probability value of <0.05 was regarded as significant. 39 All differences between ST and FRT groups not reaching this level are designated NS.
Results
Twenty-three dogs entered the study. One died at 1 hour from CPR-induced hemomediastinum, 1 developed sagittal sinus thrombosis, and 1 developed subdural hematoma before arrest. Before arrest, all variables were normally distributed, and no differences were found between the groups.
Controlled variables before and after cardiac arrest (Table 1) were not significantly different between the groups. The changes in arterial blood gases after arrest reflect the changes of inhaled mixture and ventilatory parameters described in "Materials and Methods."
Asphyxiation time was 406 ± 78 seconds in the ST and 411 ± 56 seconds in the FRT group; CPR time was 149 ± 80 seconds in the ST and 172 ± 86 seconds in the FRT group. Therefore, the total duration of insult was not different between the groups. All dogs were successfully resuscitated after cardiac arrest, within 5 minutes of CPR. In the ST group, resuscitation was achieved with an average dose of 2.1 mg epinephrine (range 1.5-3.0 mg) and 26.5 meq NaHCO 3 (range 18-37 meq); in the FRT group, an average dose of 2.2 mg epinephrine (range 2.0-3.0 meq) and 27.6 meq NaHCOj (range 24-31 meq) (NS) was needed. In the ST group, 8 of 10 dogs developed secondary ventricular fibrillation and required countershocks, whereas in the FRT group, all dogs required countershocks (NS). After restoration of spontaneous circulation, all dogs MAP, mean arterial blood pressure; SSP, sagittal sinus pressure. Values are mean ± SD; n = 10 dogs for each measurement.
•Different from prearrest values within groups (p<0.05, ANOVA with Bonferroni correction); no significant difference between groups.
in both groups required NaHCO 3 and norepinephrine for MAP control (NS).
Cardiovascular variables were not different between groups. Except for heart rate, there were no significant changes from prearrest values ( Table 2) .
Before arrest, gCBF ( Figure 1 ) was normally distributed and not different between groups. CBF measured between 15 and 30 minutes after resuscitation showed a significant increase in the ST group and no change from prearrest values in the FRT group. Subsequently, gCBF decreased significantly compared with prearrest values in both groups and remained low until the end of the 6-hour experiment. Differences between groups were significant only at 15-30 minutes (p = 0.005) and 4 hours (p = 0.039) after resuscitation. When comparing normalized changes from prearrest values (Figure 2) , gCBF was reduced significantly more in the ST than the FRT group from 1 to 4 hours after cardiac arrest.
Calculated cerebral perfusion pressure (Table 1 ) was constant throughout the study, with no differences between groups. Calculated cerebral vascular resistance was significantly different between groups only during the initial hyperemic phase, when it decreased significantly in the ST group but remained unchanged in the FRT group. CMRO 2 ( Figure 3 ) in the ST group increased with gCBF during the hyperemic phase at 15 minutes and declined below prearrest values from 2 to 6 hours, but remained unchanged in the FRT group; the initial hypermetabolism recorded in the ST group was absent in the FRT group (p = 0.042). The delayed reduction in CMRO 2 was more severe in the ST than the FRT group, but the difference was significant only at 2 hours (p = 0.02).
Somatosensory Evoked Potentials
In 3 dogs, SEPs could not be recorded or analyzed because of technical problems. Thus, data are reported from 9 dogs in the ST group and 8 dogs in the FRT group.
Before arrest, the SEP waveform consistently showed a first positive wave (P,) (latency range 12-16 msec), a first negative wave (N,) (latency range 18-24 msec), and a secondary positive wave (P 2 ) (latency range 28-40 msec) (Figure 4) . Later waves were present but were not analyzed. Prearrest latencies appeared stable, normally distributed, and comparable in the two groups (Table 3 ). The amplitudes were highly variable both between and within dogs, but there were no significant differences between groups. The prearrest pattern was comparable with that described in dogs by other investigators. 3 *
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During asphyxiation, P 2 was depressed first, followed by progressive depression of the P|-N, complex. SEPs were flat at 5-6 minutes of asphyxiation and persisted flat during cardiac arrest in all dogs.
After restoration of spontaneous circulation, the pattern of recovery was consistent in all dogs. At 15-30 minutes, P,, N,, and P 2 were present in all dogs, although with an extremely simplified waveform ( Figure  4) . The positive activity following the P,-N, complex after resuscitation appeared fused in a single, wide, delayed wave (latency range 60-70 msec), progres- sively increasing in amplitude. P, and N, recovered prearrest latency ( Figure 5 ) and amplitude ( Figure 6 ) during the first hour after arrest without differences between groups. The variability of the latencies of P, and N, was significantly increased at 15-30 minutes after arrest but normalized between 2 and 3 hours without significant differences between groups. 
FIGURE 1. Cerebral blood flow (mean ± SD) before and after 7-minute asphyxial cardiac arrest in dogs treated with anoxic reperfusion + superoxide dismutase + deferoxamine (FRT) vs. standard treatment (ST). -k significant change from prearrest values within the group (p<0.05, ANOVA with Bonferroni correction); • significant difference between groups (p<0.05, t test for unpaired data).
4). In the ST group, P 2 remained a high-voltage, delayed wave throughout the study, occasionally presenting an indentation at its prearrest latency but never reaching a definition from the remaining positive activity in any of the 9 dogs. The latency of P 2 clearly reflected the significant alteration in waveform morphology induced by the ischemic insult. In the FRT group, the wide, delayed, high-amplitude wave clearly separated into a P 2 wave at prearrest latency between 2 and 3 hours after arrest. The waveform recovered prearrest morphology and remained well defined throughout the experiment.
The enhanced recovery of P 2 in the FRT group com-
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-zo- pared with the ST group was reflected in significant differences in P 2 latency between the groups ( Figure  5 ). The coefficient of variation of P 2 latency was significantly increased in both groups early after arrest. At 3 hours after cardiac arrest, the variability of P 2
FIGURE 2. Cerebral blood flow as normalized changes from prearrest values (mean ± SD). • significant difference between groups (p<0.05, t test for unpaired data).
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Pi Pi latency in the FRT group recovered prearrest values but remained significantly lower than in the ST group, in which it never normalized. N,-P 2 amplitudes also reflected these differences in recovery. This amplitude was consistently higher than prearrest values in the ST group; in the FRT group, it decreased below prearrest values at 2 hours and progressively normalized thereafter ( Figure 6 ). However, differences between groups did not reach significance.
Discussion
Our results suggest that the combination of anoxic reperfusion, SOD, and deferoxamine administered at the beginning of CPR significantly modifies the recovery of CBF and SEPs after asphyxial cardiac arrest in dogs without affecting cardiovascular-pulmonary function. We interpret this as a possible positive effect of the treatment tested. However, long-term outcome experiments are required to assess the therapeutic benefit of this treatment protocol.
The technique used for CBF measurement, i.e., hydrogen slow saturation with flow calculated on the washout curve, yielded prearrest values very consistent among dogs, comparable with those described in dogs by other authors using a similar method.
40
- 41 Calculating flow from a 15-minute washout curve is based on the assumption of a steady state and represents an arbitrary averaging, especially in the case of rapidly changing flow as in the immediate postarrest period.'• 42 - 43 However, since CBF was measured at exactly the same time in all dogs, we believe the comparison between groups to be legitimate. Cardiovascular and pulmonary variables did not differ between groups at any time; therefore, the differences in CBF after arrest may be attributed to the administered treatment. This prevented the usually observed increase in CBF immediately following reperfusion and ameliorated the subsequent persistent reduction in CBF.
In the absence of evaluating long-term neurologic recovery, we estimated acute functional recovery using SEPs. Although a correlation between the recovery of electrically evoked responses and neurologic outcome has not been assessed in this model, SEPs have been used extensively as a measure of neuronal functional recovery and are considered to be a sensitive index (for review see Ref. 44) . The SEP peaks in humans and animals are presumed to be generated by specific brain structures 45 : P, from the thalamocortical projection, N, from the somatosensory cortex, and P 2 from associative areas. The variability of latencies is considered to be correlated with the degree of pathology.
* Although P, and N, latencies recovered rapidly after ischemia in both groups, P 2 recovery was different between groups. The failure of the waveform to recover prearrest morphology in the ST group shows that in these dogs the sequence of neuronal activation, altered by ischemia, remained abnormal throughout the experiment, whereas it normalized in the FRT dogs. The combined treatment tested, therefore, effectively normalized the activity and variability of the associative areas, i.e., decreased postanoxic pathology.
The complete functional recovery of the thalamocortical projection and the somatosensory cortex early after resuscitation in both groups suggests that the insult to the brain may have been too mild to reliably assess the effectiveness of the combined treatment. Asphyxial cardiac arrest of 7 minutes' duration has been described to severely impair neurologic function, similar to 10 minutes of ventricular fibrillation cardiac arrest. 32 However, the mechanism by which the neurologic impairment is achieved may be different since asphyxiation (with hypoxemia, hypercarbia, acidemia, and hypotension preceding cardiac arrest) adds to and alters the ischemic insult. The degree of postischemic cerebral hypoperfusion and the consistent impairment of the more integrated neuronal functions were sufficiently severe to show an effect of the combined treatment, although this may have been blunted by the relative mildness of the insult.
The significance and mechanisms of the effects of this combined treatment on cerebral blood flow and oxygen consumption are unclear. Recirculation after --oST(n*9)
•FRT(n-8) TIME (HOURS) FIGURE 6 . 43 Initial hyperemia following long periods of ischemia represents a prerequisite to neuronal functional recovery, 47 and the absence of hyperemia correlates with regional neuronal vulnerability. 42 The combined treatment tested in this study prevented hyperemia and could therefore be expected to exert a negative effect on the recovery of function.
On the other hand, the severity of delayed hypoperfusion may be associated with correspondingly more severe impairment of functional recovery 48 and has been speculated to impair neuronal recovery by adding a secondary ischemic insult to the brain, especially if not matched by a corresponding lowering of metabolic rate i,2.4i Furthermore, treatments that ameliorate (inhomogeneous) CBF reduction after ischemia might also improve cerebral functional recovery.
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The combined treatment tested in this study improved delayed hypoperfusion paralleled by a nonsignificant but similar improvement in oxygen consumption. Therefore, it could be expected to-and indeed did-improve neuronal functional recovery. This ameliorating functional effect was associated with apparently contradictory effects on CBF. A possible explanation is that prevention of the therapeutic reactive hyperemia on one hand and amelioration of the delayed hypoperfusion and neuronal function on the other may represent unrelated epiphenomena of the effects of SOD and deferoxamine. This hypothesis finds support in the available data on the characteristics and mechanism of action of SOD and deferoxamine.
The effectiveness of SOD in ischemia has been disputed since exogenous SOD does not easily penetrate the cell membrane 30 or pass the blood-brain barrier. 51 However, SOD need not penetrate into the brain to exert its protective effect. In acute hypertension, SOD prevents cerebral hyperemia through a vascular mechanism; superoxide anion radicals, produced intracellularly by neurons and endothelial cells, escape through the anion channel into the extracellular space. Here, oxygen free radicals induce vascular smooth muscle relaxation, alter blood-brain barrier permeability, and damage endothelial cells, all effects that are prevented by SOD (see Ref. 25) . Thus, the absence of hyperemia in this study may well be the result of the vascular effect of SOD. A global measurement of CBF, as we used, cannot detect whether the absence of hyperemia is the result of a more homogeneous distribution of flow that could ameliorate the subsequent reduction of CBF. 4243 However, 4 mg/kg SOD administered after 15 minutes of incomplete cerebral ischemia in rats did not affect the degree of delayed hypoperfusion or the homogeneity of flow distribution. 52 This suggests that, in our study, amelioration of the delayed CBF reduction should be attributed entirely to the effect of deferoxamine. Since SOD and deferoxamine act on two subsequent steps of the same pathway, and since deferoxamine freely passes the blood-brain barrier and the cell membrane, 53 the pathogenesis of delayed hypoperfusion could be the result of the intracellular effect of free radicals. Among the mechanisms that have been advocated in this pathogenesis is the increased production of vasoactive substances generated via cyclooxygenase and lipoxygenase metabolism of arachidonate, 1 which is stimulated by hydroperoxides, 26 products of iron-catalyzed lipid peroxidation. 20 The neuronal functional improvement can be the result of the effect of SOD, preventing alterations in endothelial and blood-brain barrier permeability and consequent edema. On the other hand, although a cause-effect relation has not been established, delayed hypoperfusion and neuronal functional impairment are considered results of the same cascades of events. 2 Since SOD alone does not affect the degree of delayed hypoperfusion, 52 the amelioration of functional recovery must be the result of the effect of deferoxamine alone or of the combination of the drugs. Both SOD and deferoxamine administered after 15 minutes of cardiac arrest in dogs decrease membrane lipid peroxidation in the brain. 54 However, deferoxamine effectively protects against the loss of lipid double bonds and the impairment of ionic homeostasis whereas SOD does not, 5556 and deferoxamine alone improves survival with normal neurologic function after 6 minutes of cardiac arrest in rats. 30 Having used a combined treatment, we could not distinguish the effects of the single agents.
The reactions leading to the formation of oxygen free radicals are very fast, 20 even at low tissue oxygen tensions. Therefore, ventilation with N 2 for 30 seconds may provide an additional chance for anti-free radical therapy to act, allowing the delivery of drugs to the brain before oxygen, without affecting resuscitation. In our study, however, this possibility was not fully utilized since only SOD was administered by intraaortic bolus, probably leaving the initial intracellular effects of oxygen free radicals unaffected because the buildup of deferoxamine administered by i.v. infusion was certainly much slower.
This combined treatment improved but did not normalize CBF and exerted only a minor, nonsignificant effect on oxygen metabolism, suggesting that either the dose of 20 mg/kg deferoxamine was insufficient to chelate iron completely or that iron chelation does not affect some other important mechanism of cell injury. Deferoxamine, even at 200 mg/kg, reduces but does not normalize the tissue concentrations of indicators of lipid peroxidation, which are increased after 15 minutes of cardiac arrest. 55 The administration of lidofiazine, however, significantly enhances this effect of deferoxamine. 54 Thus, iron chelation represents a very promising therapeutic tool but may require additional agents to counteract other known mechanisms of cell injury, such as the calcium-triggered activation of phospholipase.
In conclusion, the combination of anoxic reperfusion with SOD and deferoxamine administered after 7 minutes of asphyxial cardiac arrest in dogs abolishes the initial cerebral reactive hyperemia, ameliorates delayed postischemic CBF reduction, and enhances normalization of somatosensory evoked responses. Thus, the single agents should be tested alone and with other agents in outcome models of prolonged cardiac arrest to assess both the pathogenetic hypothesis and the ultimate therapeutic value.
